Literature DB >> 25541018

A summary for molecular regulations of miRNAs in breast cancer.

Shaymaa M M Yahya1, Ghada H Elsayed2.   

Abstract

BACKGROUND: Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related death among women worldwide. MicroRNAs (miRNAs) are naturally-occurring, non-coding small RNA molecules that can modulate protein coding-genes, which makes it contributing to nearly all the physiological and pathological processes. Progression of breast cancer and resistance to endocrine therapies have been attributed to the possibility of hormone-responsive miRNAs involved in the regulation of certain signaling pathways.
METHODOLOGY: This review introduces better understanding of miRNAs to provide promising advances for treatment. miRNAs have multiple targets, and they were found to regulate different signaling pathways; consequently it is important to characterize their mechanisms of action and their cellular targets in order to introduce miRNAs as novel and promising therapies.
RESULTS: This review summarizes the molecular mechanisms of miRNAs in TGF-beta signaling, apoptosis, metastasis, cell cycle, ER-signaling, and drug resistance.
CONCLUSION: Finally, miRNAs will be introduced as promising molecules to be used in the fight against breast cancer and its developed drug resistance.
Copyright © 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cell cycle; Drug resistance; Metastasis; miRNA

Mesh:

Substances:

Year:  2014        PMID: 25541018     DOI: 10.1016/j.clinbiochem.2014.12.013

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  19 in total

Review 1.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

2.  Effect of SMYD3 on the microRNA expression profile of MCF-7 breast cancer cells.

Authors:  Dongju Chen; Lei Liu; Xuegang Luo; Ai Mu; Lihua Yan; Xiaoying Chen; Lei Wang; Nan Wang; Hongpeng He; Hao Zhou; Tongcun Zhang
Journal:  Oncol Lett       Date:  2017-06-06       Impact factor: 2.967

3.  Could miR-34a Inhibition be Used as a Tool to Overcome Drug Resistance in MCF-7 Cells Treated with Synthesized Steroidal Heterocycles?

Authors:  Shaymaa M M Yahya; Mervat M Abd-Elhalim; Abdou O Abdelhamid; Emad F Eskander; Ghada H Elsayed
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

4.  MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?

Authors:  Geraldine Cizeron-Clairac; François Lallemand; Sophie Vacher; Rosette Lidereau; Ivan Bieche; Celine Callens
Journal:  BMC Cancer       Date:  2015-07-05       Impact factor: 4.430

5.  MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27.

Authors:  Yong-qiang Ren; Fengkui Fu; Jianjun Han
Journal:  Med Sci Monit       Date:  2015-05-06

Review 6.  Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.

Authors:  Andrew McGuire; James A L Brown; Michael J Kerin
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

7.  Differential microRNA expression profiles in tamoxifen-resistant human breast cancer cell lines induced by two methods.

Authors:  Peng Ye; Cheng Fang; Hui Zeng; Yu Shi; Zhongya Pan; Nairui An; Keli He; Li Zhang; Xinghua Long
Journal:  Oncol Lett       Date:  2018-01-10       Impact factor: 2.967

8.  Identification of Cholangiocarcinoma Associated with Hepatolithiasis via the Combination of miRNA and Ultrasound.

Authors:  Wei Jiang; Xiaofei Deng; Ting Zhu; Yuya Wei; Zhen Lei; Meimei Guo; Jiong Yang
Journal:  Cancer Manag Res       Date:  2020-03-12       Impact factor: 3.989

Review 9.  MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?

Authors:  Oronzo Brunetti; Antonio Russo; Aldo Scarpa; Daniele Santini; Michele Reni; Alessandro Bittoni; Amalia Azzariti; Giuseppe Aprile; Sabina Delcuratolo; Michele Signorile; Antonio Gnoni; Loredana Palermo; Vito Lorusso; Stefano Cascinu; Nicola Silvestris
Journal:  Oncotarget       Date:  2015-09-15

10.  Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemia.

Authors:  Aleksandra Butrym; Justyna Rybka; Dagmara Baczyńska; Rafał Poręba; Grzegorz Mazur; Kazimierz Kuliczkowski
Journal:  Oncol Lett       Date:  2016-08-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.